Amt für Gesundheit — Fürstentum Liechtenstein
Liechtenstein AG · Liechtenstein · europe
Liechtenstein's Office of Public Health — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under harmonised Swiss / EEA pharmaceutical and medical device frameworks as appropriate.
Regulatory Profile
- Agency type
- national regulator
- Region
- europe
- Country
- Liechtenstein
- Leech status
- unregulated
- Last ASH review
- 2026-05-27
Relevant Regulation Codes
- Liechtenstein Heilmittelgesetz (HMG) — adopting most Swissmedic decisions under the customs union with Switzerland
- EEA / EU pharmacovigilance reporting arrangements via the EEA Joint Committee
- EU MDR 2017/745 (applied via EEA mechanism)
Prescriber Requirements
- Liechtenstein Ärztekammer–registered physician — order required for any biomedical device application
- Allied health professional application under physician supervision per institutional protocol
Supply Chain & GMP
Dual recognition: Swissmedic-authorised products are typically marketable in Liechtenstein under the Swiss-Liechtenstein customs union; German-language labelling. Standard cold-chain conditions.
Import/Export Rules
Liechtenstein Amt für Lebensmittelkontrolle und Veterinärwesen clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.
Reimbursement Context
Liechtensteinische Krankenversicherung (LAK / OKP) coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed under the basic insurance.
ASH Editorial Notes
Leech-specific pathway not independently verified by ASH; Liechtenstein's regulatory environment is uniquely dual — sharing Swissmedic authorisation under the Swiss-Liechtenstein customs union while also being an EEA member that applies EU pharmaceutical law via the EEA Joint Committee; whether this dual regime captures live-organism medical devices in a distinct way has not been independently mapped by ASH.
Related Jurisdictions
EMA — European Union
Centralised EU authority for medicinal products — leeches sit on the border between MDR-regulated device and HMPC traditional herbal medicine framework.
European Commission — European Union
EU executive body responsible for the Medical Device Regulation (MDR) — the legal instrument that frames how Member States CE-mark leech products.
MHRA — United Kingdom
Post-Brexit UK regulator — accepts EU CE marks during transition, with UKCA marking now phased in for Great Britain (Northern Ireland follows EU MDR via Windsor Framework).
BfArM — Germany
Germany classifies medicinal leeches as a finished medicinal product (Fertigarzneimittel) — uniquely strict among EU Member States and requires marketing authorisation via BfArM.